Affera combines mapping technology with a catheter capable of performing radiofrequency and pulsed field ablation.

This approval is expected to help in treatment of persistent AFib and for RF ablation of CTI dependent atrial flutter.

Less than a year after obtaining an FDA approval for its first foray into pulsed field ablation, Medtronic has done it again.

Analyst Travis Steed from Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report) and keeping the price ...

Medtronic plc added a second U.S. FDA pulsed field ablation (PFA) device approval to its scorecard with the agency’s ...

Needham analyst Michael Matson has maintained their neutral stance on MDT stock, giving a Hold rating today. Michael Matson’s rating is ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...

Hurt by a slowdown in procedures for its heart valve replacement devices, Edwards said it is working with hospitals to manage ...

With both candidates in Texas, Trump takes aim at his rival's immigration policy while Harris pledges to codify the right to abortion. Brothers Lyle and Erik Menendez are serving jail sentences ...

Investing.com-- Gold prices fell slightly in Asian trade on Friday, remaining in sight of record highs hit earlier this week as anticipation of a tight U.S. presidential election kept traders biased ...

If convicted of the charges, 34-year-old Guillermo Renderos faces 14 years and five moths to ...